October Pharma Co. (OCPH) Key Statistics
19 reported figures for October Pharma Co. — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 6.18B
- Dividend yield
- 0%
Income (latest fiscal year)
- Revenue
- EGP 544.13M
- Net income
- EGP 88.26M
- EBITDA
- EGP 163.69M
- Free cash flow
- EGP 15.74M
Balance sheet
- Total assets
- EGP 606.15M
- Total debt
- EGP 234.15M
Growth
- Revenue growth
- 3.9%
- Profit growth
- 160.91%
- EPS growth
- 160.9%
Per share
- EPS (fiscal year)
- 3.68
- Dividend per share
- 0.75
Technical
- RSI (14)
- 49.8
- 50-day moving average
- EGP 236.14
- 200-day moving average
- EGP 151.77
- Beta (1Y)
- 0.57
Shares
- Shares outstanding
- 24M
- Free float
- 11.73%
Source: company disclosures to the Egyptian Exchange via TradingView. Fiscal-year figures are as last reported; technical readings refresh with market data.